Home  |  Patients  |  Physicians  |  In the News  |  Hours/Location  |  Contact
        Bio-Identical Hormones
             Hormones for Women
             Hormones for Men
             Hormone Drug Info
      • Erectile Dysfunction
      • HCG Weight Loss
      • NasoNeb & Sinus Meds
      • Pain Management
      • LDN, MS & Autoimmune
      • Sterile Clean Room
      • Veterinary Compounding

             Drug Shortages
             AMA Recognition
             Legal Information
             Insurance Services
        Nutritional Products
             Product Review Process
             Synergy Blends
        Veterinary Products
             Drug Shortages

        What is the Rose Garden
        Compression Hosiery
        Bras & Camisoles
        Swim Suits
        Hats & Turbans
        Lymphedema Garments

     • Rental, Repair, Sales
     • NasoNeb & Sinus Meds
     Breast Pumps & Nursing
     • Product List

        Product List
        Product Review Process
        Synergy Blends
        Veterinary Products
        •  Compounds
        •  Supplements

        PCAB Accreditation
        Legal Information
      • Staff Members
        History of Mark Drugs

Content 7



Naltrexone, Low-Dose Naltrexone (LDN) | Research Trials Reference | Helpful Reference Links

LDN and Auto-immune disease, HIV/Aids, Cancer and MS:

  • LDN and HIV/AIDS
    • Per Dr. Bihari, patients who took LDN had decreased deterioration of CD4+ cells.
    • In Dr. Bihari’s practice, 350 AIDS patients were given LDN, along with standard AIDS therapies. Over 7 years, studies showed that about 85% of patients had no detectable levels of the virus, with no side effects and higher efficacy than most AIDS treatments.
  • LDN and Cancer
    • LDN has been shown to inhibit tumors in the laboratory setting (Mechanism: production of endorphins and enkephalins which work on tumors’ opioid receptors and cause cancer cell death), and may also increase natural killer cells.
    • In Dr. Bihari’s practice, he reported having 300 patients who had failed standard cancer treatments. Of those, about half of them showed improved with LDN, after 4 to 6 months of initiating therapy, and greater than 33% showed tumor shrinkage.
  • LDN and MS
    • Low endorphin levels impair helper T cells which lead to myelin destruction. LDN restores endorphin levels.
    • In Dr. Bihari’s practice, he had about 400 M.S. patients.
    • After starting LDN, less than 1% of patients experienced a new M.S. attack.
  • LDN and Auto-immune disease
    • In treating other autoimmune diseases, all patients had a decrease in illness progression, but there were patients who experienced remission.
 LDN 2016 Information ButtonLDN effective treatment for Diseases ButtonLDN effective treatment for Diseases ButtonLDN FAQs Frequently Asked Questions ButtonLDN Auto immune disease, HIV, Cancer, MS ButtonLDN Conference Events October 5, 2013 ButtonBuy LDN at Mark Drugs compounding Pharmacy Button

Top of page


Home | Contact | Roselle (630) 529-3400 | Deerfield (877) 419-9898 | Careers | Sitemap